최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기ACS medicinal chemistry letters, v.11 no.2, 2020년, pp.166 - 171
Na, Hyo Gyeong (Bio and Drug Discovery Division , Korea Research Institute of Chemical Technology , PO Box 107, Daejeon 34114 , Republic of Korea) , Imran, Ali (Bio and Drug Discovery Division , Korea Research Institute of Chemical Technology , PO Box 107, Daejeon 34114 , Republic of Korea) , Kim, Kyuneun (Bio and Drug Discovery Division , Korea Research Institute of Chemical Technology , PO Box 107, Daejeon 34114 , Republic of Korea) , Han, Hong Sik (Bio and Drug Discovery Division , Korea Research Institute of Chemical Technology , PO Box 107, Daejeon 34114 , Republic of Korea) , Lee, Young Jin (Bio and Drug Discovery Division , Korea Research Institute of Chemical Technology , PO Box 107, Daejeon 34114 , Republic of Korea) , Kim, Myung-Jin (AM Sciences , C-912, SK V1 GL Metrocity, 128, Beobwon-ro, Songpa-gu, Seoul , 05854 , Republic of Korea) , Yun, Chang-Soo (Bio and) , Jung, Young-Sik , Lee, Joo-Youn , Han, Soo Bong
Hepatitis B virus (HBV) remains a major health concern with 260 million people having been infected globally, and approximately 680,000 deaths have occurred annually from cirrhosis and liver cancer. The modulation of HBV capsid assembly has emerged as a promising therapeutic approach for curing chro...
Cole, A.G.. Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection. Current opinion in pharmacology, vol.30, 131-137.
Lam, Angela M., Espiritu, Christine, Vogel, Robert, Ren, Suping, Lau, Vincent, Kelly, Mollie, Kuduk, Scott D., Hartman, George D., Flores, Osvaldo A., Klumpp, Klaus. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus. Antimicrobial agents and chemotherapy, vol.63, no.1, e01734-18-.
Liu, Na, Zhao, Fabao, Jia, Haiyong, Rai, Diwakar, Zhan, Peng, Jiang, Xuemei, Liu, Xinyong. Non-nucleoside anti-HBV agents: advances in structural optimization and mechanism of action investigations. MedChemComm, vol.6, no.4, 521-535.
Wong, Vincent, Chan, Henry. Chronic Hepatitis B: A Treatment Update. Seminars in liver disease, vol.33, no.2, 122-129.
Feng, Song, Gao, Lu, Han, Xingchun, Hu, Taishan, Hu, Yimin, Liu, Haixia, Thomas, Andrew W., Yan, Zhipeng, Yang, Song, Young, John A. T., Yun, Hongying, Zhu, Wei, Shen, Hong C.. Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection. ACS infectious diseases, vol.4, no.3, 257-277.
European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.67, no.2, 370-398.
Terrault, Norah A., Bzowej, Natalie H., Chang, Kyong‐Mi, Hwang, Jessica P., Jonas, Maureen M., Murad, M. Hassan. AASLD guidelines for treatment of chronic hepatitis B. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.63, no.1, 261-283.
World Health Organization Global Hepatitis Report 2017 Blach S. 2019
Boucle, Sebastien, Lu, Xiao, Bassit, Leda, Ozturk, Tugba, Russell, Olivia Ollinger, Amblard, Franck, Coats, Steven J., Schinazi, Raymond F.. Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectors. Bioorganic & medicinal chemistry letters, vol.27, no.4, 904-910.
Zhang, F., Wang, G.. A review of non-nucleoside anti-hepatitis B virus agents. European journal of medicinal chemistry, vol.75, 267-281.
Fanning, Gregory C., Zoulim, Fabien, Hou, Jinlin, Bertoletti, Antonio. Therapeutic strategies for hepatitis B virus infection: towards a cure. Nature reviews. Drug discovery, vol.18, no.11, 827-844.
Diab, Ahmed, Foca, Adrien, Zoulim, Fabien, Durantel, David, Andrisani, Ourania. The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals. Antiviral research, vol.149, 211-220.
Zhou, Zheng, Hu, Taishan, Zhou, Xue, Wildum, Steffen, Garcia-Alcalde, Fernando, Xu, Zhiheng, Wu, Daitze, Mao, Yi, Tian, Xiaojun, Zhou, Yuan, Shen, Fang, Zhang, Zhisen, Tang, Guozhi, Najera, Isabel, Yang, Guang, Shen, Hong C., Young, John A. T., Qin, Ning. Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms. Scientific reports, vol.7, 42374-.
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.